Latest news for Rakovina Therapeutics (OTC:RKVTF) Stock

Rakovina Therapeutics Inc is engaged in drug discovery research, preclinical and clinical development, and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Its oncology pipeline has the potential to deliver biomarker-driven treatments for patients across multiple tumor types. Some of its products in the pipeline include kt-2000 AI, kt-3000 series. Rakovina gained exclusive use of the Deep Docking AI Platform, enabling it to significantly speed up identifying potential drugs for DNA damage response.

RAKOVINA THERAPEUTICS INC by RAKOVINA THERAPEUTICS INC

Rakovina Therapeutics Inc

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates Galiano Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GAU#AMEX">GAU</a>) with a Buy and lowers the price target from $4.6 to $3.1.

News

Price Target

Reiteration

Analyst Ratings

HC Wainwright & Co. Reiterates Buy on Galiano Gold, Lowers Price Target to $3.1

2024 Full Year Operating Highlights
<ul>
<li>Performed 14.7 million patient visits, compared to 13.6 million in 2023.</li>
<li>Treated 957,000 new patients, compared to 932,000 in 2023.</li>
<li>Increased system-wide sales1&nbsp;9%, compared to 12% in 2023.</li>
<li>Delivered comp sales2&nbsp;of 4% on par with 4% in 2023.</li>
<li>Sold 46 franchise licenses, compared to 55 in 2023.</li>
<li>Expanded total clinic count to 967, up from 935 clinics at December 31, 2023.
<ul>
<li>Opened 57, refranchised 3, and closed 18 (including 3 relocations) for a total of 842 franchised clinics at December 31, 2024, compared to 800 at December 31, 2023.</li>
<li>Refranchised 3 and closed 7 (including three non-traditional corporate units on Airforce bases) for a total of 125 company-owned or managed clinics at December 31, 2024, compared to 135 at December 31, 2023.</li>
</ul>
</li>
</ul>

General

JYNT

The Joint Corp Performed 14.7M Patient Visits In 2024, Compared To 13.6M In 2023

Stifel analyst Benjamin Nolan upgrades Canadian National Railway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNI#NYSE">CNI</a>) from Hold to Buy and lowers the price target from $132 to $120.

Upgrades

Stifel Upgrades Canadian National Railway to Buy, Lowers Price Target to $120

2024 KSP Drilling Highlights 1,2
<ul>
<li>0.62 gpt Au, 2.84 gpt Ag, 0.14 % Cu over 121.50 metres ETW (CP-24-001)</li>
<li>4.56 gpt Au, 1.34 gpt Ag, 0.06 % Cu over 11.00 metres ETW, including 19.30 gpt Au, 2.30 gpt Ag, 0.08 % Cu over 2.50 metres ETW (CP-24-001)</li>
<li>0.71 gpt Au, 0.69 gpt Ag, 0.03 % Cu over 381.47 metres ETW, including 0.50 gpt Au, 0.78 gpt Ag, 0.03 % Cu over 117.47 metres ETW and 1.07 gpt Au, 0.68 gpt Ag, 0.03 % Cu over 139.00 metres ETW (CP-24-004)</li>
<li>6.44 gpt Au, 3.40 gpt Ag, 0.23 % Cu over 7.61 metres ETW (CP-24-008)</li>
<li>1.82 gpt Au, 2.85 gpt Ag, 0.11 % Cu over 25.00 metres ETW including: 9.79 gpt Au, 7.50 gpt Ag, 0.21 % Cu over 2.50 metres ETW (CP-24-008)</li>
<li>0.49 gpt Au, 2.15 gpt Ag, 0.02 % Cu over 75.15 metres ETW (CP-24-011)</li>
<li>0.72 gpt Au, 1.86 gpt Ag, 0.05 % Cu over 41.69 metres ETW (KP-24-004)</li>
</ul>

Commodities

Markets

Skeena Resources Announced Drill Results From The 2024 Exploratory Drilling Program At The KSP Property In The Golden Triangle Of British Columbia

Stifel analyst Suthan Sukumar initiates coverage on TELUS Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIXT#NYSE">TIXT</a>) with a Buy rating and announces Price Target of $5.

Initiation

TIXT

Stifel Initiates Coverage On TELUS Intl with Buy Rating, Announces Price Target of $5

LGTY: 17% &#x7C; <a href="https://www.benzinga.com//node/43024940">Logility shares are trading higher after a Reuters report suggesting the company is working with an investment bank to explore a potential sale. The company said it has no comment to make concerning any speculation.</a>
&nbsp;
SEZL: 20% &#x7C; <a href="https://www.benzinga.com//node/43024921">Sezzle shares are trading higher after the company announced it expects to exceed its previously provided 2024 revenue and income guidance.</a>
&nbsp;
DOYU: 31% &#x7C; <a href="https://www.benzinga.com//node/43024905">DouYu shares are trading higher following the company appointed Simin Ren's as Co-CEO and declared a special cash dividend.</a>

Movers

Trading Ideas

DOYU

LGTY

SEZL

Market-Moving News for January 16th

Tech

SMTK

Smartkem Has Completed The First Sale Of Its Truflex Semiconductor Materials To Its Joint Development Partner, Shanghai Chip Foundation Semiconductor Technology For Use By Chip Foundation In The Co-development Of A New Generation Of microLED-Based Backlight Technology For Liquid Crystal Displays

D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) with a Buy and maintains $18 price target.

GOVX

D. Boral Capital Maintains Buy on Geovax Labs, Maintains $18 Price Target

Health Care

CBUS

Cibus Has Established Production Standards For Its Proprietary Rtds Gene Editing Process For The Development And Commercialization Of Plant Traits

Truist Securities analyst Jordan Levy downgrades Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) from Buy to Hold and lowers the price target from $100 to $65.

Downgrades

ENPH

Truist Securities Downgrades Enphase Energy to Hold, Lowers Price Target to $65

Saudi Arabia has unveiled a joint venture between the state oil company Aramco and the state mining company Ma'aden. The collaboration focuses on extracting <a target="_blank" href="https://www.benzinga.com/topic/lithium" rel="noreferrer noopener">lithium</a>, a vital component in batteries for electric vehicles (EVs), renewable energy storage, and electronics. Commercial production is expected by 2027.
"We expect that this partnership will leverage the world's leading upstream enterprise to apply significant low-cost advantages, industry experience, technological innovation, and an integrated supply chain ecosystem," <a target="_blank" href="https://www.aramco.com/en/news-media/news/2025/aramco-plans-transition-minerals-jv-with-maaden" rel="noreferrer noopener">said</a> Nasir K. Al-Naimi, Aramco's upstream president.
The venture aligns with Saudi Arabia's Vision 2030, an ambitious economic transformation plan designed to reduce dependency on oil by developing sectors like mining, technology, and renewable energy.
Vision 2030 targets unlocking $2.5 trillion of mineral resources, including lithium, copper, and gold, while increasing mining's GDP contribution from $17 billion to $64 billion.
Demand for lithium has surged due to the global shift toward green energy. According to Aramco, domestic lithium needs could increase twenty-fold by 2030, supporting the production of 500,000 EV batteries and 110 gigawatts of renewable energy capacity.
The new joint venture aims to explore direct lithium extraction (DLE) technologies and tap into high-concentration deposits within the region. In contrast to traditional evaporation methods, DLE bypasses the need for lithium ponds, allowing faster extraction rates, minimized environmental impact, and reduced water consumption, which are crucial factors in arid climates.
The project also builds on Saudi Arabia's first successful lithium extraction from oilfield brine last December, which was conducted in collaboration with a local startup, Lihytec. Ma'aden is making strides in other commodities, unveiling promising gold and copper deposits at Wadi Al Jaww and Jabal Shayban.
Ma'aden CEO Bob Wilt <a target="_blank" href="https://www.maaden.com.sa/en/news/details/602" rel="noreferrer noopener">noted</a> that these findings are part of one of the world's largest single-jurisdiction exploration programs. "We are committed to establishing mining as the third pillar of the Saudi economy, in line with Vision 2030," he stated.
Strengthening domestic copper production is a priority since the country imports most of its copper—365,000 tons annually. While this demand could double by 2035, the country might secure some of this increasingly important metal from Pakistan as it <a target="_blank" href="https://www.benzinga.com/m-a/24/04/38336936/saudi-arabia-near-deal-for-stake-in-gold-copper-mine-project-in-pakistans-troubled-province" rel="noreferrer noopener">evaluates a stake</a> in Barrick Gold's Reko Diq project.
Price Watch: Global X Lithium &amp; Battery Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LIT#NYSE">LIT</a>) is up 0.79% year-to-date.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43013685/research-firms-and-industry-insiders-clash-copper-agree-on-trumps-risk" target="_blank" rel="noreferrer noopener">Research Firms And Industry Insiders Clash On Copper, Agree On Trump's Risk</a></li>
</ul>
Photo by Piotr Swat on Shutterstock

Legal

BATT

CARZ

DRIV

KARS

Saudi Arabia Advances Lithium Plans, Looks Beyond Oil For Commodity Diversification

Needham analyst Ryan MacDonald reiterates Definitive Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) from Hold to Hold.

Needham Reiterates Hold on Definitive Healthcareto Hold

WIIM

Logility shares are trading higher after a Reuters report suggesting the company is working with an investment bank to explore a potential sale. The company said it has no comment to make concerning any speculation.

Sezzle shares are trading higher after the company announced it expects to exceed its previously provided 2024 revenue and income guidance.

Contracts

LASE

Laser Photonics Scored A Three-system Order For Its CleanTech Industrial Roughening Laser Systems From Proman, A Switzerland-based Global Petrochemical Producer, For Its New Mexico Facility

DouYu shares are trading higher following the company appointed Simin Ren's as Co-CEO and declared a special cash dividend.

DOCN

DigitalOcean Holdings shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target to $41.

Wells Fargo analyst Gabe Hajde downgrades Ball (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALL#NYSE">BALL</a>) from Equal-Weight to Underweight and lowers the price target from $56 to $49.

BALL

Wells Fargo Downgrades Ball to Underweight, Lowers Price Target to $49

Symbotic shares are trading higher after the company announced an agreement to acquire Walmart's Advanced Systems and Robotics business.

MCRB

Seres Therapeutics Received $50M Installment Payment Related To The Company's Previously Announced Sale Of Its Vowst Business To Société Des Produits Nestlé

Rakovina Therapeutics prices $1.25M private offering

RKVTF

Rakovina Therapeutics

Comments

Rakovina Therapeutics

News

Latest news for Rakovina Therapeutics (OTC:RKVTF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga